Utilization Analysis of Antifungal Drugs in Nanjing Area during 2013 and 2015
- VernacularTitle:2013~2015年南京地区常用抗真菌药利用分析
- Author:
Lulu WANG
;
Hui LIU
;
Liang DAI
- Keywords:
Antifungal drugs;
Application analysis;
DDDs;
Consumption sum;
Invasive fungal infection
- From:
China Pharmacist
2017;20(2):317-320
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the utilization of antifungal drugs in Nanjing area, and provide clinical reference for the rational use of antifungal drugs. Methods:According to the sales data of antifungal drugs in 34 hospitals in Nanjing area from 2013 to 2015, the utilization of antifungal drugs was analyzed in respects of consumption sum, DDDs and DDC. Results:The consumption sum and use of antifungal drugs increased year by year. The maximum amount of consumption sum growth rate was 41. 13%. Triazole drugs oc-cupied the top of consumption sum during the past three years, and the sales amount accounted for more than 60% of all. In term of consumption sum, voriconazole, fluconazole, itraconazole and caspofungin ranked top 4 of antifungal drugs. Clotrimazole topical prepa-rations and oral itraconazole ranked top 2 of DDDs, and caspofungin, micafungin and voriconazole ranked top 3 of DDC. Conclusion:The clinical application of antifungal drugs continues to increase during 2013 and 2015. Invasive fungal infection is a lethal factor at high risk. Choosing reasonable, effective, safe and economic of antifungal drugs is the first principle in clinical treatment.
